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A
major hurdle ingeneticmanipulation
of organisms inmolecular and cellular
biology (e.g., gene knock-outs or
knock-ins and ultimately nonviral gene
therapy) is the inefficiency of current DNA
delivery systems. While viral vectors are the
most effective gene delivery systems and
have been used in several clinical trials,16
their intrinsic immunogenicity, potential side
effects (e.g., insertionalmutagenesis), limited
nucleic acid packaging capacity, and difficul-
ties of mass production will restrict their
application in gene therapy. Nonviral gene
delivery carriers include cationic lipids and
polymers that are nonimmunogenic, flexible
in packaging different kinds and sizes of
nucleic acids, relatively easy to handle, and
have potential for mass production.7 This is
why they remain an attractive long-term op-
tion for gene delivery, despite their currently
relatively poor transfection efficiency.811
Systematic exploration and understanding
of the structureactivity relationships of non-
viral transfection reagents are therefore ne-
cessary for the development of efficient and
safe alternatives as gene transfer tools.
Molecules synthesized for the purpose of
transfection usually include some or all of
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ABSTRACT Efficient DNA delivery into cells is the prerequisite of the genetic
manipulation of organisms in molecular and cellular biology as well as, ultimately,
in nonviral gene therapy. Current reagents, however, are relatively inefficient, and
structureactivity relationships to guide their improvement are hard to come by.
We now explore peptide dendrimers as a new type of transfection reagent and
provide a quantitative framework for their evaluation. A collection of dendrimers
with cationic and hydrophobic amino acid motifs (such as KK, KA, KH, KL, and LL) distributed across three dendrimer generations was synthesized by a solid-
phase protocol that provides ready access to dendrimers in milligram quantities. In conjunction with a lipid component (DOTMA/DOPE), the best reagent,
G1,2,3-KL ((LysLeu)8(LysLysLeu)4(LysLysLeu)2LysGlySerCys-NH2), improves transfection by 610-fold over commercial reagents under their respective
optimal conditions. Emerging structureactivity relationships show that dendrimers with cationic and hydrophobic residues distributed in each generation
are transfecting most efficiently. The trigenerational dendritic structure has an advantage over a linear analogue worth up to an order of magnitude. The
success of placing the decisive cationic charge patterns in inner shells rather than previously on the surface of macromolecules suggests that this class of
dendrimers significantly differs from existing transfection reagents. In the future, this platform may be tuned further and coupled to cell-targeting moieties
to enhance transfection and cell specificity.
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the following molecular recognition features: cationic
groups for electrostatic DNA binding, a hydrophobic
part to facilitate transmembrane transfer, and specific
recognition entities.1215 Among the systems used for
nucleic acid delivery are lipid-based systems, polymers,
and lipidpolymer hybrid vectors. Lipid small mol-
ecules include Gemini surfactants,14 liposomes,16 or
lipidoids17 that associate DNA cargo with a lipid pack-
age to facilitatemembrane transfer. Cationic polymeric
systems have been used in gene delivery based on
their electrostatic interactions with negatively charged
DNA that are enhanced by multivalency.18 Oligo- or
polymeric materials include linear or branched struc-
tures such as polyethylene imine (PEI),1921 cationic
peptides22 such as polylysine or polyarginine2329
(sometimes in combination with a targeting seq-
uence30), and also dendrimers31 such as polyamidoa-
mine (PAMAM),3238 degraded PAMAM,38 PAMAM-
poly(ethylene glycol) block copolymers,39,40 polypropy-
leneimine (PPI),4143 and polylysine dendrimers.24,44
The intrinsic ability of a transfection reagent to
bind and deliver nucleic acids can be changed by
attachment of lipid groups,4548 amino acids (e.g.,
arginine36,37,42,4951 and phenylalanine52) on the
macromolecule surfaces. In addition, some surface
modifications were shown to improve the vector
stability,37 membrane permeability,53 and/or endoso-
mal escape.54,55 Combinations of lipids and polymeric
systems that are jointly administered have also been
employed and can be synergistic; that is, the transfec-
tion effects of combinations of reagents can exceed
those of individual species. Such multicomponent
vectors12,21,30,56,57 combine multivalent interactions of
the polymer with the nucleic acid and the negatively
charged cell surfacewith the ability of a lipid to facilitate
membrane crossing.30,5860 The wealth of structures
used for transfection raises the question whether the
functional properties can bemodified in a rational way.
However, there are relatively few instances in which it
was possible to correlate combinatorial or systematic
changes in the molecular structure of the transfection
reagents to a change in their properties.14,45,6163 This
is partly due to the limits of the synthetic protocols:
variation of the backbone to allow incorporation
of heterogeneous building blocks is difficult in
dendrimers, so that the character of the interior and
surface of the dendrimers is difficult to vary in a
differential manner. The limits of the synthetic degrees
of freedom had the consequence that previous anal-
yses of transfection ability focused mainly on surface
modifications.36,42,53,6466
As a result, systematic studies of the effect of back-
bone components on their gene delivery properties
of dendrimers have not been explored, and a
more rational understanding of design principles for
dendrimers capable of efficient transfection reagents
is lacking.
Our peptide dendrimers can be readily prepared by
solid-phase peptide synthesis and allow the incorpora-
tion of alternative building blocks.6773 The robust
synthesis procedure allows incorporation of hydropho-
bic, charged, or polar residues into the dendritic scaf-
fold to explore chemical and functional space. In
contrast to other transfection reagents, the character
of our transfection reagent can be varied in dendritic
layers, so that not only the surface of the transfection
reagent but also its interior is affected. Tapping the
potential of interactions of inner shell residues be-
comes possible to tune the molecular recognition
properties to support transfection. Many widely used
transfection reagents, such as PEI,57,74 are polydisperse
and often ill-defined (notwithstanding their clear utility
in everyday use), whichmay limit the stringency of any
rules even from systematic studies. By contrast, our
synthetic protocol allows the synthesis of well-defined,
fully characterized compounds at spectroscopic qual-
ity (see Supporting Information). Ready access to the
compounds allows a unique opportunity to develop a
molecular understanding and systematic study of re-
lated transfection reagents. Dendrimers were adminis-
tered together with the structurally well-defined lipid
combina;tion of DOTMA/DOPE (D/D) that further en-
hances transfection.30,60
In this study, we exploit the modularity of dendritic
structures with different amino acid building blocks
and charge distributions within the dendrimers to
obtain structureactivity relationships. Figure 1 shows
the structures of a series of third generation dendri-
mers incorporating a branching Lys and the dyad LysX
(where X is leucine, histidine, or alanine; Figure 1, X1, X3,
and X5). The 11 dendrimers have similar sizes and
architectures but varying constituent parts. Their struc-
tures vary in the charge per dendrimer, the ratio of
molecular weight and charge (Mw/charge), and the
charge distribution within the dendrimers, and the
data for this collection suggest that these parameters
influence gene delivery in a systematic way. The
dendrimer/lipid formulations show marked improve-
ments in transfection compared to commercial re-
agents such as PEI (up to 8-fold) and Lipofectamine
L2000 (6-fold better).
RESULTS AND DISCUSSION
Design and Synthesis of the Peptide Dendrimer Transfec-
tants. To test whether the peptide dendrimer scaffold
would be suitable for transfection, third generation
dendrimers with two amino acids between branching
units were synthesized by fast and reliable solid-phase
peptide synthesis to yield milligram quantities of
water-soluble dendrimers (Figure 1 and Table S1).
Within the dendrimer scaffolds, two molecular re-
cognition elements, cationic and hydrophobic groups
that are recurring features in a variety of transfec-




KWOK ET AL. VOL. 7 ’ NO. 5 ’ 4668–4682 ’ 2013
www.acsnano.org
4670
general requirement for cationic and hydrophobic
functionality was addressed by incorporating permuta-
tions of the molecular recognition elements KK, KA, KH,
KL, and LL in different spheres of the dendrimer frame-
work: either on the periphery or distributed across
the three dendrimer generations (see Figure 1B for the
sequences). These groups represent combinations of
hydrophobicgroupsofdifferent sizes (A, L),withapositive
charge (K, pKa∼9.5) and a group with buffering capacity
around neutral pH (H, pKa ∼6.5) that has been shown to
facilitate endosomal escape.54,55 Given the multitude of
potential combinations, the following considerations
were made to limit the number of compounds, yet still
cover substantial functional diversity. In each of the eight
tested dendrimers, the outermost layer (generation 3)
contains at least eight lysines to provide a cationic
interaction with anionic cell-surface groups and DNA,
paired upwith either Lys, Leu, Ala, or His. Figure 1C shows
the different charge patterns that our collection covers.
To address the question of size dependence on transfec-
tion, three peptide dendrimers were tested as dimers.
Peptide dendrimers were initially used for transfec-
tion alone (Figure 2A) and then with the lipids, DOTMA
and DOPE (w/w 1:1, Figure 2B), that synergistically
enhanced the transfection efficiency. Enhancements
for lipid/dendrimer/DNA complexes (compared to
dendrimer/DNA complexes alone) ranged between
1 and 2 orders of magnitude for the better transfection
Figure 1. Schematic representation of the peptide dendrimers studied. (A) General structure of the peptide dendrimers used
in this studyhighlighting the three generations, the attachmentpoint for dimerization (a Cysmarkedby agray arrow), and the
general formula for this collection of dendrimers. The table in (B) shows the specific amino acids distributions in each
dendrimer. The nomenclature describes dendrimers by the generation G and the amino acid pattern in these generations,
where the hydrophobic amino acids motif LL is substituted by cationic amino acid motifs, such as KA, KH, KA, or KL. For
example, the most charged dendrimer G1,2,3-KK contains 28 cationic lysines (16 in G3, 8 in G2, and 4 in G1) plus 7 neutral
branching lysines. The dimers of G1,2,3-KL, G2,3-KL, and G3-KL are [G1,2,3-KL]2, [G2,3-KL]2, and [G3-KL]2, respectively, and
other dimers are named analogously. (C) Overview of the charge patterns in this dendrimer collection, showing the
arrangements of double-charged (KK), charged (KL, KA, KH, RL), and uncharged patterns (LL). The C-terminal Cys of the
dendrimers (markedby a gray arrow) is a primary amide (RCONH2), and theN-termini are free amines. The structures in (D,E)
show the scaffolds of the most (G1,2,3-KL) and least effective (G3-KL) transfecting agents, respectively. These two examples
highlight the key structural differences in the charge distribution: the cationic charges are distributed across the dendrimer in
G1,2,3-KL. In G3-KL, the cationic charges are only present on the surface (i.e., in the third generation). The chemical structures
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reagents, for example, 50-fold in [G1,2,3-KL]2 (at an N/P
ratio of 5) or 30-fold in G1,2,3-RL (at an N/P of 10) (see
Figures 2 and 6 and Figure S1 in the Supporting
Information). A further increase beyond one weight
equivalent of the lipid componentD/D in the formulation
diminished the transfection efficiency (see Supporting
Information, Figure S2). Most of the lipidpeptide
dendrimer hybridswere shown to be at least as efficient
in luciferase transfection experiments when compared
with other reagents (e.g., PEI and L2000) in commonuse
that also present cationic and hydrophobic features.
In HeLa cells, the best formulation, G1,2,3-KL/lipid,
shows clear improvements in the expression of the
luciferase transgene compared to commercial and
widely used reagents: 10-fold compared to D/D alone
(w/w to DNA 4:1), 8-fold more than polyethylene imine
(PEI), and up to 6 times as much as Lipofectamine 2000
under their respective optimal conditions recom-
mended by the manufacturers.
Exploration of StructureActivity Relationships in a Family
of Peptide Dendrimers. To allow a systematic quantitative
analysis of the role of charge within the dendrimers,
Figure 2. Transfection of HeLa cells mediated by dendrimerDNA complexes with or without the addition of a lipid
component (DOTMA/DOPE). The addition of the lipid component within the dendrimer DNA complexes improved
transfection by at least 30-fold. HeLa cells (1 104) were transfected with a luciferase-expressing plasmid (pCI-Luc; 0.25 μg)
using dendrimers at different N/P ratios andDOTMA/DOPE (D/D) (also known as lipofectin) (0.25 μg). The luminescenceof cells
was analyzed 24 h post-transfection. The luminescence of the cells treated by the dendrimer complexes was normalized by
dividing by the luminescence of cells treated with a D/D DNA complex (w/w 1:1) to yield the percentage (%) of transfection. (A)
Transfection using dendrimer and DNA. (B) Transfection using D/D, dendrimer, and DNA. Controls: (C1) Untreated cells; (C2) cells
treated with the plasmid pCI-Luc alone; (C3) cells treated with L2000; (C4) cells treated with PEI (ng 3; mean( SD). The N/P ratio
refers to the ratio between protonated nitrogen atoms of the dendrimer and DNA phosphate groups. The optimal N/P ratio for
transfectionmayvarybetweendendrimers; therefore, it is important to test differentN/P ratios to identify theoptimal transfection
formulations of dendrimers in our collection. Error bars refer to the mean( SD for experiments carried out in triplicate. The data
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transgene expression, DNA binding, and cell toxicity
were correlated to theMw/charge ratio and the charge
distribution in the three dendrimer shells. One or
two lysines were incorporated into each branch of
the first, second, and third shells, and the total number
of protonatable lysines varied between 8 and 28 (and
thus a maximum total dendrimer charge between
16 and 36, including the free N-termini in addition to
Lys side chains).
Variation of Dendrimer Charge. Figure 3 shows
luciferase reporter gene expression data for dendri-
mers in which the cationic charges of lysine have been
replaced by the hydrophobic group leucine bearing an
identical number of carbon centers. Plotted against the
Mw/charge ratio, the dendrimers fall into two groups:
6 of 8 data points are linearly correlated. Although
the range of Mw/charge values is necessarily limited,
the corresponding change in transfection is more
than 10-fold. The data suggest that dendrimers with
more cationic character are better able to transfect.
The slope of this curve is shallow; that is, a change of
100 in Mw/charge brings about only a 3-fold increase
of the luciferase transgene readout. By contrast, the
total absolute charge per dendrimer was less well-
correlated to transfection efficacy (as evidenced
by more scattered data, especially at high N/P ratios;
see Supporting Information, Figure S3). To probe
whether the observed structureactivity relationship
of the Mw/charge ratio and transfection is an intrinsic
property or due to the effect of a specific formulation,
transfection experiments were carried out at varying
ratios of dendrimer to DNA (i.e., N/P ratios). The optimal
N/P ratio between protonated nitrogen atoms from
the dendrimer and phosphate groups from the DNA is
known to vary between structurally modified transfec-
tion reagents. A comparison of transfection trends at
a range of N/P ratios (2.520) allows the separation of
intrinsic effects as a function of the structure of the
transfection reagents from those that are brought
about by adjustable external factors. Here identical
behavior was observed, namely, that more cationic
dendrimers transfect more efficiently, suggesting that
the effects are intrinsic properties of the dendrimers
(see Supporting Information, Figure S4). The transfec-
tion efficiency was measured by luciferase expression
in HeLa cells (see Supporting Information, Figure S4)
and shows a similar trend, with lowerMw/charge ratios
exhibiting better transfection efficiencies. Overall, this
analysis suggests that the Mw/charge ratio is a signifi-
cant parameter governing transfection by peptide
dendrimers.
Charge Distribution of the Dendrimers Affects Trans-
fection Efficiency. The correlation described in the
previous section serves to distinguish dendrimers
obeying an apparent broad trend from dendrimers for
which transfection is further enhanced (albeit by only
210-fold). Indeed, these outliers share a structural
feature, namely, one charged lysine in each branching
unit of each generation (i.e., G1,2,3-KL, [G1,2,3-KL]2).
To further investigate the effect of charge distribution
of the dendrimers on transfection, the transfection
efficiency of the dendrimer with charged lysines in the
third generation (G3-KL) was compared against dendri-
mers with charged lysines in both the second and third
generations (G2,3-KL) and all generations (G1,2,3-KL)
(Figure 4). G1,2,3-KL transfects up to 5 times more effec-
tively than dendrimer G2,3-KL, whereas the dendrimer
bearing charged lysines only in the third generation
(G3-KL) transfects least effectively. Uniform distribution
of the KL dyad in each dendrimer generation gave better
transfection agents than grouping hydrophobic residues
in one or two generations (Figure 4).
This effect is independent of the partner group
of lysine. Replacing leucine by histidine or alanine
(in the context of identical amino acid composi-
tion, e.g., in dendrimers G1,2,3-KA and G1,2,3-KH)
gave dendrimers with transfection efficiency compar-
able to G1,2,3-KL and 5-fold better than G2,3-KL and
G3-KL (Figure 5).
Figure 3. Molecularweight (Mw) to charge ratio governs the
transfection efficiency of dendrimers. The majority of the
dendrimers tested (9) exhibits a broad trend: a changeof 100
in theMw/charge ratio brings about a∼3-fold increase of the
luciferase transgene readout. A subset of the dendrimers (0)
exhibits further enhancement (by ∼210-fold) above this
trend, and these outliers are the most efficient transfection
reagents in this study. These compounds share a structural
feature, namely, one charged lysine in eachbranching unit of
each generation, suggesting that this distribution contri-
butes to an improved transfection efficiency. Luminescence
values for HeLa cells transfected with a luciferase-expressing
plasmid (pCI-Luc) in the presence of peptide dendrimers and
D/D (measured 24 h after transfection). The luminescence
values were normalized by dividing them by the analogous
values for cells treated with a D/D DNA complex (w/w 1:1,
0.25 μg) to generate the% of transfection. The percentage of
transfection at anN/P ratio (i.e., the ratiobetweenprotonated
nitrogen atoms of the dendrimer and DNA phosphate
groups) of 5:1. Figure S4 shows data for three additional
N/P ratios for transfection that exhibit similar trends. Condi-
tions: 1  104 HeLa cells transfected with 0.25 μg pCI-Luc.
Error bars refer to themean( SD for experiments carried out
in triplicate in three independent experiments except for
G2,3-KK, where n = 3 (see Figure S1 for a comparison of the
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Dendrimers in which the identity of the cationic
group was changed (swapping lysine for arginine in
dendrimers G3-RL, G2,3-RL, and G1,2,3-RL) transfected
similarly well and allowed insight into whether the
distribution effect would be specific for lysine or apply
more generally to any cationic charge (Figure 6), over-
riding the features (the higher pKa of the guanidinium
Figure 4. Effect of the charge distribution and size of the dendrimers on transfection. Dendrimers with one hydrophobic
and one cationic amino acid within each generation are more effective in transfection. Luminescence values for HeLa
cells transfected with a luciferase-expressing plasmid (pCI-Luc) in the presence of peptide dendrimers G3-KL, G2,3-KL, and
G1,2,3-KL (black, n=1) and their respective dimers (red, n=2) with D/D (measured 24 h after transfection). The luminescence
valueswere normalized by dividing themby the analogous values for cells treatedwith a D/DDNA complex (w/w 1:1, 0.25 μg)
to generate the % of transfection. The figure contains data for the N/P ratios of (A) 2.5:1, (B) 5:1, (C) 10:1, and (D) 20:1.
Conditions: 1 104 HeLa cells transfected with 0.25 μg pCI-Luc. Error bars refer to themean( SD for experiments carried out
in triplicate. The data shown represent three sets of independently reproducible experiments.
Figure 5. Comparison of the transfection efficiency of den-
drimers composed of a KL dyad against dendrimers with
a KH or KA dyad. Substituting the hydrophobic amino acid
leucine with alanine or histidine does not affect the overall
transfection efficiency. Luminescence values for HeLa cells
transfected with a luciferase-expressing plasmid (pCI-Luc)
in the presence of peptide dendrimers G1,2,3-KL, G1,2,3-KA,
and G1,2,3-KH with D/D (measured 24 h after transfection).
The luminescence valueswere normalized by dividing them
by the analogous values for cells treated with a D/D DNA
complex (w/w 1:1, 0.25 μg) to generate the % of transfec-
tion. The figure contains data for the N/P ratios of (A,blue)
2.5:1, (B,red) 5:1, (C,green) 10:1, and (D,violet) 20:1. Condi-
tions: 1  104 HeLa cells were transfected with 0.25 μg
pCI-Luc. Error bars refer to the mean ( SD for experiments
carried out in triplicate. The data shown represent three sets
of independently reproducible experiments.
Figure 6. Effect of the charge distribution of the RL-based
dendrimers on transfection. The distribution of charges
over multiple generations of a dendrimer scaffold leads to
a higher transfection efficiency with arginine instead of
lysine as the cationic residue. Luminescence values for HeLa
cells transfected with a luciferase-expressing plasmid (pCI-
Luc) in the presence of peptide dendrimers G3-RL, G2,3-RL,
and G1,2,3-RL with D/D (measured 24 h after transfection).
The luminescence valueswere normalized by dividing them
by the analogous values for cells treated with a D/D DNA
complex (w/w 1:1, 0.25 μg) to generate the % of transfec-
tion. The figure contains data for the N/P ratios of (A,blue)
2.5:1, (B,red) 5:1, (C,green) 10:1, and (D,violet) 20:1. Condi-
tions: 1  104 HeLa cells were transfected with 0.25 μg
pCI-Luc. Error bars refer to the mean ( SD for experiments
carried out in triplicate. The data shown represent three sets
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side chain (∼12) compared to the primary amino acid
lysine and its charge delocalization). In this series,
the best transfection agent is the G1,2,3-RL, followed
by G2,3-RL and G3-RL as the least efficient structure.
Dendrimers in which the cationic charge is distributed
in each generation are clearly better than those with
the same number of charges at the surface only. These
results underline the importance of placing charges in
the inner shells and suggest that the charge distribution
in the dendritic scaffold affects efficiency in addition to
the overall charge and the Mw/charge ratio.
Size Dependence. To study the effect of the size on
transfection, the transfection efficacies of dimeric den-
drimers (prepared and purified as single compounds)
were compared to their monomers (Figure 4). Dimer-
ization improved transfection about 3-fold at a lower
N/P ratio of 2.5 (Figure 4A), although this effect dis-
appears at higher N/P ratios (5, 10, and 20, Figure
4BD). Thus, a simple increase in charge (by increasing
the number of monomer equivalents) is not necessarily
effective, whereas charge position and density are in-
dependent of the N/P ratio. Together with previous
studies that had shown that an increase in generations
of lysine dendrimers leads to better transfection24,44
these observations lead to the conclusion that it is not
an increase of the dendrimer size by dimerization that
improves transfection, but rather the number of charges,
their location, and the number of dendrimer generations
that govern transfection efficiency instead.
However, a critical size appears to be reached with
the three-generational dendrimer: first and second
generation analogues are weak candidates. The first
generation dendrimers have shown a very low transfec-
tion ability and do not bind DNA efficiently. A second
generation analogue shows detectable transfection
only at high N/P ratios (Figure 7).
A further control addresses whether there is parti-
cipation of the cysteine thiol group in the core. Dendrimer
Ala-G1,2,3-KL (in which alanine replaces the core cysteine)
shows similar transfection to dendrimer G1,2,3-KL, sug-
gesting that this cysteine is not participating in the crea-
tion of larger aggregates or affecting transfection viaother
effects (Supporting Information, Figure S10).
Dendrimers TransfectMore Efficiently thanTheir Linear
Counterparts. To compare the transfection effects of
the structural differences between linear and dendritic
structures, a linear peptide consisting of 32 lysines
(K32) was compared against an all-lysine dendrimer
(G1,2,3-KK) (Figure 8). At N/P ratios of 2.5, 5, 10, and
20, G1,2,3-KK transfected 210-fold better than the
complexes made of K32 at the respective N/P ratios.
The G1,2,3-KK-DNA complexes also transfected 2.5 and
4 times better than the PEI- or D/D-DNA complexes,
respectively. Thus, the data suggest an advantage for a
dendritic structure over a linear structure for transfection
worth up to an order of magnitude. This observation
reinforces the conclusion from comparisons of dendri-
mers with their linear analogues (specifically a linear
polylysine polymerwith 170 amines vs a sixth generation
dendrimer with 128 amines and 126 lysine residues) that
indicated a 100-fold advantage for dendrimer-mediated
gene expression.75 However, in a more recent study of
Figure 8. Transfection by peptide dendrimer G1,2,3-KK
in comparison to other relevant systems. The dendrimer
G1,2,3-KK (bearing 28 protonable lysines) was compared to
a linear peptide composed of 32 lysines (K32) at four N/P
ratios (left to right: 2.5, 5, 10, and 20). Depending on the N/P
ratio, the dendrimeric system transfects 410-fold more
efficiently than a linear analogue, suggesting that structural
features influence transfection. Further controls are 25K
PEI (N/P ratios of 5 (left) and 10 (right), D/D (w/w ratios
of 1 and 4)), a transfection experiment in the absence of
transfection reagent (C1), and the luminescence of un-
treated cells (C2). The luminescence valueswere normalized
by dividing them by the analogous values for cells treated
with a D/D DNA complex (1:1 w/w, 0.25 μg) to generate
the percentage of transfection. Conditions: 1  104 HeLa
cells transfected with 0.25 μg pCI-Luc. Error bars refer
to the mean ( SD for experiments carried out in triplicate.
The data shown represent three sets of independently
reproducible experiments.
Figure 7. Relationship between the number of generations
of dendrimers and transfection. An increase in dendrimer
generations invariably leads to an increase in the transfec-
tion efficiency (regardless of the N/P ratio). Luminescence
values for HeLa cells transfectedwith a luciferase-expressing
plasmid (pCI-Luc) in the presence of peptide dendrimers of
one (1G), two (2G), and three generations (3G) with D/D
(measured 24 h after transfection). The luminescence values
were normalized by dividing them by the analogous values
for cells treated with a D/D DNA complex (w/w 1:1, 0.25 μg)
to generate the % of transfection. The figure contains data
for the N/P ratios of (A,blue) 2.5:1, (B,red) 5:1, (C,green) 10:1,
and (D,violet) 20:1. Conditions: 1  104 HeLa cells were
transfected with 0.25 μg pCI-Luc. Error bars refer to the
mean( SD for experiments carried out in triplicate. The data
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polymeric systems, a linear and a dendrimeric polylysine
structure transfected similarly well, while a hyper-
branched polylysine performed best.76
Cellular Uptake and Internalization of the Lipid-
Dendrimer-DNA Complexes. The uptake of Cy5-labeled
dendrimer-DNA complexes was quantified by flow
cytometry. To distinguish cell-surface-bound com-
plexes from internalized complexes, the transfected
cells were washed with a heparin salt that should
compete with DNA-cell-surface interactions removing
the fluorescent label (see Supporting Information,
Figure S5). Thus, a Cy5 signal should arise only from
the cells that had internalized their cargo. Uptake was
studied under conditions similar to transfection. Here,
all complexes were internalized by more than 90% of
the cells (Figure 9), but much less are transfected and
transfection efficiency varied considerably (10100-
fold) between dendrimers. Thus, uptake is necessary
but not sufficient for successful transfection. The G3-KL
complexes were most effectively internalized, with a
mean fluorescence intensity (MFI) 2-fold higher than
the best transfectant, G1,2,3-KL (Figure 9A), despite
their poor transfection efficiency. G1,2,3-KK DNA com-
plexes were taken up more efficiently than the linear
lysine-DNA complexes. The observation that uptake
appears to be uniformly good for peptide dendrimer
complexes is remarkable as uptake of PAMAM/DNA
into brain capillary endothelial cells had tobe enhanced
(to 70%) by modification with transferrin, although this
may be partly due to cell-specific differences.77
Role of the Lipid Component. The addition of a
lipid component (D/D) to our dendrimer-DNA com-
plexes leads to a slightly more compact nanoparticle
(∼1020% smaller) than in the absence of lipid and
the resulting complexes fall in a range between 38 and
50 nm in hydrodynamic size (see Supporting Informa-
tion, Table S2).
The functional properties are affected in the follow-
ing way:
(a) Transfection efficiency. D/D is known to promote
transfection,60 and we accordingly observed an en-
hancement over transfection of DNA in the absence of
lipid. When dendrimer-DNA complexes were supple-
mented with D/D lipid, the total enhancement of
Figure 9. Cellular uptake of lipid-dendrimer-DNA complexes. More than 90% of cells take up the lipid-dendrimer-DNA
complexes, indicating that their internalization is not the limiting factor for transfection. (A) Dendrimers containing the
motif KL; (B) dendrimers containing the motif KL, KH, and KA; (C) uptake of linear and dendritic KK peptides (Compounds:
a, G1,2,3-KK, G2,3-KK, and G3-KK; b, G2,3-KL; c, G1,2,3-KL; d, G3-KL; e, G1,2,3-KL, G1,2,3-KA, and G1,2,3-KH; f, K32; and g,
G1,2,3-KK). Transfected cells were washed (3, 1 h) in heparin solution (2 mg/mL) to remove surface-bound DNA. The cells
were then treated with trypsin, and the internalization of the DNA complexes was measured by flow cytometry (RFU: relative
fluorescence units). Control: untreated cells. Conditions: 5 104 HeLa cells were transfected for 4 h with Cy5-labeled, 0.75 μg
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transfection was typically increased by 3050-fold
(Figure 2).
(b) Cytoxicity. Crystal violet assays showed some
toxicity caused by the lipid-dendrimer-DNA complexes
in HeLa cells (Figure 10A). The majority of dendrimers
showed high cell viability: 27 out of 36 formulations
allowed 60% or more cells to survive after transfection
with dendrimer-D/D, despite the cytotoxicity of D/D
alone (∼50% cell death). Thus, the dendrimers partly
offset (or at least do not increase) the inherent toxicity
of D/D. For the best transfecting dendrimers, toxicity
was greater, reaching ∼60% cell viability for G1,2,3KL
and 6080% for the dimer [G1,2,3KL]2. In addition to
inherent toxicity, it is possible that efficient luciferase
overexpression itself (or related effects) indirectly
leads to cell death. When comparing the structure,
Mw/charge ratio, dimerization, and charge distribution
of the dendrimers to the toxicity, no correlation was
found (see Supporting Information, Figures S6 and S7).
These comparisons imply that the molecular determi-
nants for transfection do not coincide with those
for toxicity. Importantly, these values are similar to or
lower than equivalent experiments with commercial
reagents such as L2000 (∼30% cell viability) and D/D
alone (∼50% cell viability).
(c) Endosomal escape: In the absence of lipids, the
dendrimer-DNA complexes caused either <10% or in-
significant cell toxicity (Figure 10B), further indicating
Figure 10. Cytotoxicity of dendrimer-DNA complexes in comparison to other systems. The lipid-dendrimer complexes are
less toxic than commercial reagents such as L2000. Removal of the lipid from the system decreases the toxicity drastically,
suggesting that toxicity stems from the lipid component. Cell viability wasmeasured 24 h after transfection using the nuclear
stain crystal violet at four N/P ratios (left to right: 2.5, 5, 10, and 20). Uptake of the nuclear stain was taken to indicate viable
cells, so that the absorbance of stain is proportional to the number of viable cells remaining following transfection. The crystal
violet absorbance of the cells treated by the complexes was compared to that of the untreated cells and cell viability is
reported as a percentage compared to untreated cells. (A) Viability of lipid-dendrimer-DNA complexes (with 0.25 μg D/D) and
(B) dendrimer-DNA complexes in the absence of a lipid component. For comparison, data on cells transfected with PEI (Mw
25 kDa,N/P ratios, 5 and10), D/D, Lipofectamine 2000 (C1), DNA (but no transfection reagent) (C2), anduntreated cells (C3) are
included. Conditions: 1  104 HeLa cells were transfected with 0.25 μg pCI-Luc. Error bars refer to the mean ( SD for
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that the cell toxicity observedwith lipid-dendrimer-DNA
complexes was mainly due to the lipid component.
It is possible that replacement of the lipid component
by a less toxic lipid will further reduce toxicity. Strategies
to reduce cell toxicity of our systemcanbe implemented
by substituting the lipid component to less toxic lipids78
and/or conjugating endosomal-cleavable peptide.79,80
It has been shown that good transfection is achieved
as a trade-off between low toxicity (including non-
specific binding to nucleic acids) and sufficient affinity
for DNA.45
Helper lipids are often used to promote inter-
nalization or endosomal escape.81 To distinguish be-
tween these alternatives, we compared the uptake
and internalization of Cy5-labeled dendrimer-DNA
complexes by flow cytometry (FACS) in the absence
and presence of D/D. The uptake of the D/D-dendri-
mer-DNA complexes was similar to the uptake of
the dendrimer-DNA complexes alone (see Supporting
Information, Figure S8), suggesting that any effect of
D/D is not related to internalization and implying that
its role must instead lie in improvement of endosomal
escape.
Binding andDissociation Properties of the Complexes.
Unloading of DNA cargo is an important feature of
a successful transfectant, and inefficient unloading
can contribute to poor transgene expression.45,82 To
address the binding and dissociation properties of
the lipid-dendrimer-DNA complexes, PicoGreen-labeled
DNA was used to detect binding by the fluorescence
decrease of encapsulated DNA. Addition of negatively
charged heparin leads to DNA release and restores
PicoGreen fluorescence. The heparin concentration ne-
cessary to release a fraction of DNA from the complex
serves as a relative measure of DNA affinity in the
complex. Figure S9 shows how similar most dendrimer
complexes were in the stability of their DNA complexes
and DNA unloading capabilities, dissociating at only
slightly different heparin concentrations. Only G3-KL
and [G3-KL]2 stand out: their complexes were not able
to release the DNA under the heparin challenge at all,
consistent with their poor transfection performance.
CONCLUSIONS
We have discovered a new transfection system,
consisting of cationic three-generational peptide den-
drimers and a lipid component that rivals commercial
agents in their ability to transfect mammalian cells.
Structureactivity relationships point to an underlying
tendency for dendrimers with lower Mw/charge ratios
(Figure 3) and charges distributed over the whole
dendritic structure (third, second and first generations)
to be thebest transfection reagents. By contrast, charges
concentrated on the peripheral layer only (third
generation) lead to poor transfection, and dendrimers
with charges in the two outer layers (third and second
generations) have intermediate activity. The dendrimers
with highest charge (e.g., the all-lysine dendrimer
G1,2,3-KK) are not the best reagents (being surpassed
byG1,2,3-KL, for example), suggesting that the presence
of Lys-Leu repeats over rides charge. These comparisons
suggest that structure and charge distribution are sig-
nificant additional criteria to be considered;the more
distributed the charge is, the better is the transfection
reagent;and thus the total charge is not the dominant
feature for transfection with peptide dendrimers.
Such trends as a result of charge organization have
not been observed previously because dendrimer
structures with heterogenerational features were not
easily available. Instead, dendrimer-like structures
assembled from identical monomers (and the same
repeating structure in all generations), such as PAMAM,83
PEI,84,85 or hyperbranched polyamines86 were used.
These structures needed to be significantly bigger to
be useful; for example, triazine dendrimers required 45
generations87 and PAMAM dendrimers 510 genera-
tions to be similarly effective. Indeed, increasing the size
of our peptide dendrimers by dimerization had virtually
no effect. While modulation of internal hydrophobicity
can help (e.g., by Leu replacing Lys in G1,2,3-KL),
the precise identity of relevant hydrophobic residues
appears to be immaterial (e.g., the transfection efficien-
cies of G1,2,3-KL, G1,2,3-KA, and G1,2,3-KH are similar).
Figure 11. Relationship between complex internalization
and transfection efficiency. The comparison of transfection
efficiency (measured by luciferase transgene expression
which was normalized by dividing them by the analogous
values for cells treated with a D/D DNA complex (1:1 w/w,
0.25 μg) to generate the % of transfection (see Figure 2) and
complex internalization (measured by the mean fluores-
cence intensity, MFI, after treatment with Cy5-labelled
DNA; see Figure 8) suggests that better internalization leads
to better transfection. However, this loose correlation is not
obeyedbyall peptidedendrimers used in this study. The two
outliers (i.e., mono- and dimeric G3-KL) show slow release of
DNA cargo (Figure S10), suggesting that this step has
become limiting for transfection. The identity of the dendri-
mers is annotated, and their composition can be decoded
using Figure 1B. Conditions: For internalization (x-axis), 105
HeLa cells were exposed to 0.75 μg pCI-Luc; for transfection
(y-axis), 104 HeLa cellswere transfectedwith 0.25 μgpCI-Luc.
Error bars refer to themean(SD for experiments carriedout
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The uniformly excellent uptake suggests that the
differences in the transfection performance mainly
depend on events inside the cell (Figure 11), such as
unloading of DNA, endosomal escape, or better nucle-
ar localization, which are still to be addressed in future
work. Consistent with this view, the peptide dendrimer
with the worst transfection performance (G3-KL) was
shown not to release its cargo.
Systematic studies addressing the effects of the
inner architecture of macromolecules, such as the
backbone components (and the associated param-
eters such as charge density and charge distribution)
on transfection have not, hitherto, been extensively
explored. We use an efficient synthetic protocol that
provides ready access to such deeply buried cationic
groups, making “deep modification” in inner shell
positions possible.77 Modifications to the interior of
dendrimers have also been reported in heterogeneous
dendrimeric hybrid structures88 or dendrimers incor-
porating orthogonal functional groups.89 Given that
exploration of the potential of interactions of inner
shell residues has only just begun,90 our methodology
sets the scene for further systematic exploitation
of transfection efficacy or DNA binding. In addition,
further work may address the downstream cellular
effects, for example, by integration of cell-targeting
sequences30,79,80 and/or nuclear localization signals9194
togetherwith furthermodifications, involving sugars and
other potential ligands. Our reagents are easy to prepare
and purify as defined molecules by a well-established
synthetic methodology. By combining amino acids in a
dendritic fashion, transfection reagents were developed
with properties not found in previously studied dendri-
mers or linear peptides. Peptide dendrimers are water-
soluble, do not form aggregates, and show by them-
selves no cytotoxicity. Many other reagents, such as
polymers and commercial dendrimers, are polydisperse,
while our monodisperse compounds based on natural
amino acids will make the approval process for thera-
peutic use and the definition of further structure
activity relationships simpler. The current level of effi-
ciency is encouraging and the insight into generational
charge arrangement is novel. We conclude that exploita-
tion of the chemical degrees of freedom inmaking novel
peptide dendrimers has led to more efficient, useful
reagents for transfection.
MATERIALS AND METHODS
Cell Lines, Transfection Reagents, and Plasmids. HeLa cells were
maintained in RPMI (Invitrogen, Paisley, UK) supplemented with
10% fetal calf serum (Invitrogen) and 1% penicillin/streptomycin
(Invitrogen) at 37 C in a humidified atmosphere in 5% carbon
dioxide. The plasmid pCI-Luc is derived from plasmid pCI
(Promega, Southampton,UK)with the luciferase gene inserted.82
Branched polyethylenimine (PEI) (25 kDa) was purchased from
Sigma-Aldrich (Gillingham, UK). Lipofectamine 2000 (L2000)
and lipofectin, a 1:1 (w/w) formulation of N-[1-(2,3-dioleyloxy)-
propyl]-N,N,N-trimethylammonium chloride (DOTMA) and the
neutral helper lipid dioleoyl phosphotidylethanolamine (DOPE),
were obtained from Invitrogen. PEI, L2000, and lipofectin were
used as a positive control transfection agent, in accordance with
the manufacturer's instructions.
Strategy of Dendrimer Synthesis and Characterization. A collection
of 11 peptide dendrimers consisting of three generations was
prepared by solid-phase synthesis using Fmoc/Boc protection,67,70
followed by acid cleavage from the resin and HPLC purification to
give single compounds in good yields (426% after purification)
with analytical data (HPLC, ESI-MS) consistent with the target
structures (Table S1).
Introduction of hydrophobic residues (leucine or alanine) or
histidine generated dendrimers with different charges and Mw,
while the dendrimeric structure was preserved. Three dendri-
mers were also dimerized to investigate the size dependence of
gene delivery.
General Synthetic Details58,61. Reagents were purchased in
the highest quality available from Fluka and Sigma Aldrich.
PyBOP-(benzotriazol-1-yl-oxytripyrrolidinophosphonium hexa-
fluorophosphate) and Fmoc(fluorenylmethyloxycarbonyl)-
protected amino acids were obtained from NovaBiochem
and Advanced ChemTech (Giessen, Germany). Fmoc Tenta-
Gel S RAM resin was supplied by Rapp Polymere (Tübingen,
Germany). All solvents used in reactions were bought in
analytical quality or distilled and dried prior to use. Solvents
for chromatographic purifications were distilled from com-
mercial preparation of technical quality.
Solid-Phase Peptide Synthesis (SPPS). Solid-phase peptide
synthesis was performed manually in polypropylene syringes
fittedwith a polyethylene frit and a Teflon stopcock and stopper.
Fmoc-protected amino acid (3.0 equiv) and PyBOP (3.0 equiv)
were added in N-methylpyrrolidone (NMP) to the deprotected
TentaGel S RAM resin (loading 0.24 and 0.22 mmol g1).
N,N-Diisopropylethylamine (DIEA, 5.0 equiv) was added, and
the reaction was stirred for 60 min (reaction times were pro-
longed for the amino acids after one branching unit (120 min),
after two branching units (180 min), and three branching units
(240 min)); the equivalents of amino acid, PyBOP, and diisopro-
pylamine were accordingly increased. The resin was then
washed with N-methyl-2-pyrrolidone, methanol, and dichloro-
methane (three times each). The effectiveness of the coupling
wasmonitored by the trinitrobenzenesulfonic acid (TNBS) test.95
Capping of unreacted peptide chains was carried out with a
solution of acetic anhydride/dichloromethane (DCM) (1:1 v/v) for
15 min before washing the resin again with NMP, methanol,
and DCM (three times each). The Fmoc-protecting group was
removed with a solution of piperidine/NMP (1:4 v/v) for 10 min
(applied twice). The resin was washed with NMP, methanol,
and DCM (three times each). The cleavage was carried out
using a mixture of trifluoroacetic acid/H2O/triisopropylsilane/
1,2-ethanedithiol (94:1:2.5:2.5 v/v/v/v) solution for 4.5 h.
After filtration, the peptide was precipitated in tert-butyl methyl
ether, centrifuged, and dried under vacuum. The crude peptide
was purified by preparative RP-HPLC.67
Homodimerization. Themonomericdendrimer (5mg,1equiv)
was dissolved in water (120 μL). A methanolic solution of
2,2-dithiodipyridine (aldrithiol) (45.5 mM, 0.5 equiv) was added
to the solution. After thiol-activation was completed, a second
portion of monomeric dendrimer (5 mg, 1 equiv) was added to
the reaction mixture. A solution of (NH4)HCO3 (20 mM) was
added to adjust the pH to 8. The solution was stirred for 3 h at
room temperature and then acidifiedwithwater containing 0.1%
TFA. The homodimer was purified by preparative RP-HPLC.96,97
Fluorescence Quenching Assay for DNA Binding. PicoGreen (Invitrogen)
was added toDNAanddiluted in TE buffer (10mMTris/HCl at pH
7.5; 1mMEDTA; final [DNA] = 0.002μg/μL). PicoGreenwas added
toDNA in a ratio of 1:150 (v/v) so that every 100μL of the solution
contained 0.2 μg of nucleic acid and incubated for 10 min at
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transfection reagents were diluted in TE buffer. Then D/D (50 μL;
0.2 μg) and dendrimers (50 μL, the amount depending on the
chosen N/P ratio that was varied from 0.625:1 to 40:1) were
added per well of flat-bottom 96-well plates, and DNA (100 μL;
0.2 μg) containing the PicoGreen was added to the transfection
reagents. As a control, DNA (100 μL; 0.2 μg) labeled with Pico-
Green was added to TE buffer (1, 100 μL per well). Following
30 min incubation at room temperature, TE buffer (1, 100 μL)
was added to each well. The PicoGreen signals were then
detected with a fluorescent plate reader, FLUOstar Optima
(BMG Labtech, Aylesbury, UK). The PicoGreen signals from the
complexeswere normalized against a “DNAonly” control to yield
the percentage of the PicoGreen signal detected.
Complex Dissociation Assay. DNA (100 μL; 0.2 μg) labeled with
PicoGreen was added to D/D (50 μL; 0.2 μg) and dendrimers
(50 μL, the amount depending on the N/P ratio) in a well of
flat-bottom colorless 96-well plates. As a control, DNA (100 μL;
0.2 μg) labeled with PicoGreen was added to TE buffer
(1, 100 μL). Following incubation at room temperature
(30 min), different concentration of heparin (0.2 to 1.4 U/mL,
Sigma-Aldrich) diluted in TE buffer (1, 100 μL) was added to DNA
complexes orDNAalone (0.2μg, 200μL) and incubated for a further
30min. The fluorescent signals fromPicoGreenwere recordedusing
a microplate reader (FLUOstar Optima, BMG Labtech). DNA labeled
with PicoGreen was used to normalize the signal.
Cellular Uptake of the Transfection Complexes. In a well of 24-well
plates, 105 cells were seeded 24 h prior to transfection. The cells
were transfected for 4 h with Cy5-labeled DNA prepared by
using the Mirus DNA labeling kit (Mirus, Cambridge, UK) follow-
ing the manufacturer's instructions. Each well of the cells were
transfected with complexes (500 μL) of lipofectin (0.75 μg) and
dendrimers (an N/P ratio of 5; typical stock concentration =
2.854.5 μg in 500 μL) or the positive control and Cy5-labeled
DNA (0.75μg). Following the transfection, the cells werewashed
three times with heparin (200 μL; 2 mg/mL) for 1 h to remove
the DNA complexes bound at the cell surface. The cells were
then trypsinized, resuspended in full growth medium, and
transferred to flow cytometry tubes. The cells were analyzed
by flow cytometer using CyAn ADP (Beckman Coulter, High
Wycombe, UK).
Transfection Procedure. Twenty-four hours before transfection,
1 104 HeLa cells were seeded in 100 μL of full growthmedium
in order to reach 70% confluence/well in 96-well plates. Plasmid
transfection complexes were formed by mixing the dendrimers
(100 μL, from 60 to 105 μg, dependent on N/P ratios) with D/D
(4 μg; 100 μL) and incubating this mixture with a luciferase-
expressing plasmid (pCI-Luc; 4 μg; 100 μL) in different N/P ratios
inOptiMEM (Invitrogen) for 30min at 25 C. Transfection control
complexes (e.g., PEI, lipofectin, or Lipofectamine 2000) (total
volume = 100 μL in OptiMEM) were mixed with the luciferase-
expressing plasmid (pCI-Luc) (4 μg; 100 μL) at the respective
manufacturers' recommended concentrations. Before over-
laying the DNA complexes on the cells, OptiMEM was added
to dilute the complexes so that each complex contained 0.25 μg
of DNA in a total volume of 100 μL in one well of a 96-well plate.
After removing completemedium from the cells, the complexes
were added to the plates. The plates were incubated with the
cells for 4 h at 37 C, 5% carbon dioxide. The complexes were
replaced by full growth medium for 24 h before luciferase
activity was assayed.
Transgene Expression Assay. The cells were washed twice with
PBS and incubated with reporter lysis buffer (20 μL, Promega)
for 20 min at 4 C then at80 C overnight. After the cells were
defrosted at room temperature, a luciferase assay buffer
(Promega; prepared according to the manufacturer's protocol,
100 μL) was added to each well. The luminescent product was
measured by relative light units (RLU) in a FLUOstar Optima
luminometer (BMG Labtech). The protein content of each cell
lysate was determined as follows: the lysate (20 μL) was mixed
with a Bio-Rad protein assay reagent (180 μL, Bio-Rad, Hemel
Hempstead, UK), incubated for 10 min, and the absorbance at
590 nm was measured and converted to protein concentration
using a BSA standard curve. RLU per milligram of protein
represented luciferase activity. The ratio of these two values is
the activity per protein unit (in RLU/mg). The values displayed in
Figures 24 and 8 are represented after normalization against
a control transfection experiment with D/D and are shown as
percentages.
Cell Viability. Cells were transfected as described in Transfec-
tion Procedure. Following 24 h of transfection, the medium
was removed and the cells were washed twice with PBS. The
PBS was then removed, and the cells were left to dry for 1 h at
room temperature (to allow permeation of the nuclear stain).
Crystal violet solution (50 μL of a stock solution supplied by
SigmaAldrich) was added to the cells and incubated for
15 min at room temperature. Following washing with distilled
water (five times), the cells were left to dry (approximately
30 min at room temperature to remove water), methanol
(200 μL) was added, and the suspension was incubated for
1 h at room temperature. The relative amount of the crystal
violet stain retained by viable cells was determined by the
absorbance of the methanolic solution at 550 nm.98
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